홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Ethylmorpholine → N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-1-(2-pyrimidinyl)-4-imidazolidinecarboxamide

HRID 2080961
인쇄

반응식

HRID 2080961 반응식
[CH3:1][N:2]1[CH:6]([C:7]([OH:9])=O)[CH2:5][N:4]([C:10]2[N:15]=[CH:14][CH:13]=[CH:12][N:11]=2)[C:3]1=[O:16].O.ON1C2C=CC=CC=2N=N1.Cl.C(N=C=NCCCN(C)C)C.C(N1CCOCC1)C.[Cl:48][C:49]1[C:54]([C:55]([F:58])([F:57])[F:56])=[CH:53][CH:52]=[CH:51][C:50]=1[CH2:59][NH2:60]>ClCCl.CN(C)C=O>[Cl:48][C:49]1[C:54]([C:55]([F:57])([F:58])[F:56])=[CH:53][CH:52]=[CH:51][C:50]=1[CH2:59][NH:60][C:7]([CH:6]1[CH2:5][N:4]([C:10]2[N:15]=[CH:14][CH:13]=[CH:12][N:11]=2)[C:3](=[O:16])[N:2]1[CH3:1])=[O:9]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 5

HCID 7525EthylmorpholineHCID 27239391,3-Propanediamine, N'-(ethylcarbonimidoyl)-N,N-dimethyl-, monohydrochloride2회HCID 27960291-Hydroxybenzotriazole hydrateHCID 52242072-Chloro-3-(trifluoromethyl)benzylamineHCID 671033483-Methyl-2-oxo-1-(2-pyrimidinyl)-4-imidazolidinecarboxylic acid

생성물 1

HCID 25097731
N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-1-(2-pyrimidinyl)-4-imidazolidinecarboxamide
수율 16.9%

시약·촉매·용매 2

HCID 6228Dimethylformamide용매HCID 6344Dichloromethane용매3회

실험 절차

A suspension of crude 3-methyl-2-oxo-1-(2-pyrimidinyl)-4-imidazolidinecarboxylic acid (0.6 mmol) in dichloromethane (10 ml) was treated with 1-hydroxybenzotriazole hydrate (98 mg, 0.72 mmol), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (138 mg, 0.72 mmol) and N-ethyl morpholine (0.3 ml, 2.4 mmol) was stirred at room temperature for 10 minutes. {[2-Chloro-3-(trifluoromethyl)phenyl]methyl}amine (126 mg, 0.6 mmol) was added. The reaction was diluted with dichloromethane (10 ml) and N,N-dimethylformamide (1 ml) and stirred at room temperature for 18 hours. Additional 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (138 mg, 0.72 mmol) was added and the suspension was stirred at room temperature for 5 days. The mixture was diluted with dichloromethane and the solution was washed with saturated sodium hydrogen carbonate solution, water, citric acid solution, water and brine, dried and evaporated. The residue was purified by mass-directed automated HPLC. The solid was triturated with ether/hexanes, collected and dried to give N-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-3-methyl-2-oxo-1-(2-pyrimidinyl)-4-imidazolidinecarboxamide (42 mg), LC/MS [M+H]+=414, retention time=2.30 minutes.

후처리

  1. stirringstirred at room temperature for 18 hours
  2. stirringthe suspension was stirred at room temperature for 5 days
  3. washthe solution was washed with saturated sodium hydrogen carbonate solution, water, citric acid solution, water and brine
  4. customdried
  5. customevaporated
  6. customThe residue was purified
  7. customThe solid was triturated with ether/hexanes
  8. customcollected
  9. customdried

출처 및 근거

ORD 기록
ord-1138298667df49ff89c5183beac46eb6
출처 데이터셋
uspto-grants-2011_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07932282B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트